These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 14955573)

  • 1. Complement-fixing antibodies to type 2 (Lansing) poliomyelitis virus in a normal population of a subtropical area.
    GOLDBLUM N; MELNICK JL
    J Exp Med; 1952 Aug; 96(2):175-85. PubMed ID: 14955573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A specific complement-fixation test for infection with poliomyelitis virus.
    CASALS J; OLITSKY PK; ANSLOW RO
    J Exp Med; 1951 Aug; 94(2):123-37. PubMed ID: 14861374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transitory appearance of type 2 neutralizing antibody in patients infected with type 1 poliomyelitis virus.
    SABIN AB
    J Exp Med; 1952 Jul; 96(1):99-106. PubMed ID: 14946332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development, persistence, and significance of type 2, poliomyelitis complement-fixing antibody in man.
    CASALS J; OLITSKY PK; SABIN AB
    J Exp Med; 1952 Jul; 96(1):35-53. PubMed ID: 14946327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of homotypic neutralizing antibody in human poliomyelitis three years after infection.
    WINSSER J; SABIN AB
    J Exp Med; 1952 Nov; 96(5):477-90. PubMed ID: 13000058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative studies of the virus-host relationship in chimpanzees after inapparent infection with Coxsackie viruses. I. The virus carrier state and the development of neutralizing antibodies.
    MELNICK JL; KAPLAN AS
    J Exp Med; 1953 Mar; 97(3):367-400. PubMed ID: 13052807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homotypic complement-fixing antibody in monkeys infected with type 2 poliomyelitis virus by the oral route.
    CASALS J; OLITSKY PK; SABIN AB
    J Exp Med; 1952 Jul; 96(1):55-8. PubMed ID: 14946328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some epidemiological aspects of poliomyelitis in Turkey; a serological survey for neutralizing and complement-fixing antibodies against polioviruses.
    PAYZIN S
    Bull World Health Organ; 1956; 15(1-2):339-54. PubMed ID: 13383369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poliomyelitis Lansing antibodies in three population groups in Israel.
    BERNKOPF H; LEVINE S
    Bull World Health Organ; 1955; 12(4):677-85. PubMed ID: 14379004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ohio strains of a virus pathogenic for infant mice, Coxsackie group; simultaneous occurrence with poliomyelitis virus in patients with summer grippe.
    MELNICK JL; LEDINKO N
    J Exp Med; 1950 Feb; 91(2):185-95. PubMed ID: 15409906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between serum antibodies and subclinical infections with poliomyelitis virus.
    BROWN GC; AINSLIE JD
    J Exp Med; 1951 Mar; 93(3):197-205. PubMed ID: 14824395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative neutralizing antibody patterns to Lansing (type 2) poliomyelitis virus in different populations.
    PAUL JR; MELNICK JL; RIORDAN JT
    Am J Hyg; 1952 Nov; 56(3):232-51. PubMed ID: 12996493
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantitative studies of the virus-host relationship in chimpanzees after inapparent infection with Coxsackie viruses. II. The development of complement-fixing antibodies.
    KRAFT LM; MELNICK JL
    J Exp Med; 1953 Mar; 97(3):401-14. PubMed ID: 13052808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody response of patients with poliomyelitis to virus recovered from their own alimentary tract.
    STEIGMAN AJ; SABIN AB
    J Exp Med; 1949 Oct; 90(4):349-72. PubMed ID: 18140667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological reactions of the Coxsackie viruses. I. The neutralization test; technic and application.
    MELNICK JL; LEDINKO N
    J Exp Med; 1950 Nov; 92(5):463-82. PubMed ID: 14778925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age incidence and seasonal development of neutralizing antibodies to lansing poliomyelitis virus.
    TURNER TB; HOLLANDER DH; BUCKLEY S; KOKKO UP; WINSOR CP
    Am J Hyg; 1950 Nov; 52(3):323-47. PubMed ID: 14789759
    [No Abstract]   [Full Text] [Related]  

  • 17. A complement fixation test for poliomyelitis.
    SCHMIDT NJ; LENNETTE EH
    J Exp Med; 1955 Aug; 102(2):133-50. PubMed ID: 13242739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Complement fixing and neutralizing antibodies in animals and men vaccinated against poliomyelitis].
    CAVALLO G; HAAS R
    Z Immun exp ther; 1956 Jun; 113(3):171-85. PubMed ID: 13353350
    [No Abstract]   [Full Text] [Related]  

  • 19. The adaptation of poliomyelitis virus, Lansing strain, to newborn mice and the use of their central nervous tissues for preparation of complement-fixing antigen.
    CASALS J; OLITSKY PK
    Arch Gesamte Virusforsch; 1951; 4(4):452-9. PubMed ID: 13249481
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the development and persistence of complement-fixing and neutralizing antibodies in human poliomyelitis.
    LENNETTE EH; SCHMIDT NJ
    Am J Hyg; 1957 Mar; 65(2):210-38. PubMed ID: 13410910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.